Login / Signup

Post-disclosure distress among racial and ethnic groups in a preclinical AD trial.

Marina RitchieChristian R SalazarDaniel L GillenJoshua D Grill
Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2024)
These results support continued use of current disclosure methods in preclinical AD trials.
Keyphrases
  • cell therapy
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • african american
  • stem cells